CC Cardiol Croat Cardiologia Croatica Cardiol. Croat. 1848-543X 1848-5448 Croatian Cardiac Society CC 2013_8_3-4_132 10.15836/ccar.2013.132 Extended Abstract Usage of drug-coated balloon in acute ST-segment elevation myocardial infarction?! StarcevicBorisSicajaMarioVuksanovicIlkoSebeticDrazenRaguzMiroslav University Hospital Dubrava, Zagreb, Croatia Correspondence to Boris Starcevic, Klinicka bolnica Dubrava, Avenija Gojka Suska 6, HR-10000 Zagreb, Croatia; Phone: +385-1-2902-444; E-mail: starki_pl@yahoo.com 032013 032013 8 3-4 132 132 Croatian Cardiac Society 2013 Croatian Cardiac Society KEYWORDS: coronary artery diseasedrug-coated balloonST-segment elevation myocardial infarctionpercutaneous coronary intervention

Novel balloons coated with paclitaxel (drug-coated balloon, DCB) were recently introduced in Croatia. Their usual indication is the treatment of in-stent restenosis and small vessels disease with significant stenosis.

We describe a case of usage of DCB in acute STEMI after thrombus aspiration. A 46-year old male, with a history of alcohol abuse, presented with acute anteroseptal STEMI. An emergency coronarography was performed and culprit lesion was found in mid LAD. After thrombus aspiration a DCB PTCA LAD was performed with optimal angio appearance. His clinical course was uneventful.

The paclitaxel DCB is an emerging device in percutaneous coronary intervention. Recently, this technology has rapidly evolved with newer studies which assess the value of DCB in coronary applications other than in-stent restenosis. In our oppinion, DCB can be safely used in selected cases where stent implantation could be associated with increased risk of complications (i.e. increased risk of GI bleeding). (1-4)

Literature WöhrleJ. Drug-coated balloons for coronary and peripheral interventional procedures. Curr Cardiol Rep. 2012;14(5):635–41. 10.1007/s11886-012-0290-x22825918 BelkacemiAAgostoniPNathoeHM First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J Am Coll Cardiol. 2012;59(25):2327–37. 10.1016/j.jacc.2012.02.02722503057 Navarese EP, Austin D, Gurbel PA, et al. Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials. Clin Res Cardiol. 2012. Dec 20. [Epub ahead of print]. LohJPWaksmanR. Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions. JACC Cardiovasc Interv. 2012;5(10):1001–12. 10.1016/j.jcin.2012.08.00523078727